New Prior Art Proves Eight Abbott Laboratories Patents on Ritonavir are Undeserved

While it would be better if patent offices did proper examinations and rejected all but the inventions most deserving of this intrusive government granted monopoly, it is great that public interest groups like the Public Patent Foundation ("PUBPAT") exist.

New York, NY -- August 26, 2010 -- The Public Patent Foundation (PUBPAT) announced today that it has formally asked the United States Patent and Trademark Office to reexamine eight patents held by Abbott Laboratories (NYSE: ABT) relating to the critical HIV/AIDS drug ritonavir, which is marketed by the Chicago, Illinois pharmaceutical giant under the name brand Norvir.

(Read full press release)